Eisai
4523.T
#1531
Rank
ยฃ8.70 B
Marketcap
ยฃ30.77
Share price
-0.05%
Change (1 day)
-36.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): ยฃ0.34 B

According to Eisai's latest financial reports the company's current earnings (TTM) are ยฃ0.33 B. In 2023 the company made an earning of ยฃ0.39 B an increase over its 2022 earnings that were of -ยฃ17.42 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ0.34 B-13.21%
2023 ยฃ0.39 B-2392.87%
2022 -ยฃ17.42 M-103.6%
2021 ยฃ0.48 B-39.52%
2020 ยฃ0.80 B7.3%
2019 ยฃ0.74 B17.23%
2018 ยฃ0.63 B86.06%
2017 ยฃ0.34 B-23.64%
2016 ยฃ0.44 B27.28%
2015 ยฃ0.35 B22.08%
2014 ยฃ0.28 B-46.11%
2013 ยฃ0.53 B-21.67%
2012 ยฃ0.68 B-20.72%
2011 ยฃ0.86 B-8.44%
2010 ยฃ0.94 B18.85%
2009 ยฃ0.79 B